Literature DB >> 21534574

Biomimetic screening of class-B G protein-coupled receptors.

Christian Devigny1, Francisco Perez-Balderas, Bastiaan Hoogeland, Serena Cuboni, Rudolf Wachtel, Christoph P Mauch, Katharine J Webb, Jan M Deussing, Felix Hausch.   

Abstract

The 41-amino acid peptide corticotropin releasing factor (CRF) is a major modulator of the mammalian stress response. Upon stressful stimuli, it binds to the corticotropin releasing factor receptor 1 (CRF(1)R), a typical member of the class-B G-protein-coupled receptors (GPCRs) and a prime target in the treatment of mood disorders. To chemically probe the molecular interaction of CRF with the transmembrane domain of its cognate receptor, we developed a high-throughput conjugation approach that mimics the natural activation mechanism of class-B GPCRs. An acetylene-tagged peptide library was synthesized and conjugated to an azide-modified high-affinity carrier peptide derived from the CRF C-terminus using copper-catalyzed dipolar cycloaddition. The resulting conjugates reconstituted potent agonists and were tested in situ for activation of the CRF(1) receptor in a cell-based assay. By use of this approach we (i) defined the minimal sequence motif that is required for full receptor activation, (ii) identified the critical functional groups and structure-activity relationships, (iii) developed an optimized, highly modified peptide probe with high potency (EC(50) = 4 nM) that is specific for the activation domain of the receptor, and (iv) probed the behavioral role of CRF receptors in living mice. The membrane recruitment by a high-affinity carrier enhanced the potency of the tethered peptides by >4 orders of magnitude and thus allowed the testing of very weak initial fragments that otherwise would have been inactive on their own. As no chromatography purification of the test peptides was necessary, a substantial increase in screening throughput was achieved. Importantly, the peptide conjugates can be used to probe the endogenous receptor in its native environment in vivo.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21534574     DOI: 10.1021/ja200160s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  8 in total

Review 1.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Receptors: clicking class B GPCR ligands.

Authors:  Thomas P Sakmar
Journal:  Nat Chem Biol       Date:  2011-07-18       Impact factor: 15.040

3.  Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine.

Authors:  Gemma Navarro; César Quiroz; David Moreno-Delgado; Adam Sierakowiak; Kimberly McDowell; Estefanía Moreno; William Rea; Ning-Sheng Cai; David Aguinaga; Lesley A Howell; Felix Hausch; Antonio Cortés; Josefa Mallol; Vicent Casadó; Carme Lluís; Enric I Canela; Sergi Ferré; Peter J McCormick
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

Review 4.  Structure-activity relationships for α-calcitonin gene-related peptide.

Authors:  Harriet A Watkins; Dan L Rathbone; James Barwell; Debbie L Hay; David R Poyner
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.

Authors:  Ying Li; Xuemin Zheng; Xiulin Yi; Changxiao Liu; Dexin Kong; Jianning Zhang; Min Gong
Journal:  FASEB J       Date:  2017-03-07       Impact factor: 5.191

6.  Improved GPCR ligands from nanobody tethering.

Authors:  Ross W Cheloha; Fabian A Fischer; Andrew W Woodham; Eileen Daley; Naomi Suminski; Thomas J Gardella; Hidde L Ploegh
Journal:  Nat Commun       Date:  2020-04-29       Impact factor: 14.919

Review 7.  Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders.

Authors:  Dorien Vandael; Natalia V Gounko
Journal:  Transl Psychiatry       Date:  2019-10-22       Impact factor: 6.222

8.  Conformational states of the full-length glucagon receptor.

Authors:  Linlin Yang; Dehua Yang; Chris de Graaf; Arne Moeller; Graham M West; Venkatasubramanian Dharmarajan; Chong Wang; Fai Y Siu; Gaojie Song; Steffen Reedtz-Runge; Bruce D Pascal; Beili Wu; Clinton S Potter; Hu Zhou; Patrick R Griffin; Bridget Carragher; Huaiyu Yang; Ming-Wei Wang; Raymond C Stevens; Hualiang Jiang
Journal:  Nat Commun       Date:  2015-07-31       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.